Aldoxorubicin Hydrochloride is an anthracycline-class anticancer chemotherapy agent derived from doxorubicin, engineered with structural modifications to enhance tumor selectivity. By intercalating into… Read more
Aldoxorubicin Hydrochloride is an anthracycline-class anticancer chemotherapy agent derived from doxorubicin, engineered with structural modifications to enhance tumor selectivity. By intercalating into DNA and inhibiting topoisomerase II, this cytotoxic agent disrupts replication and triggers apoptosis in malignant cells. Analytical laboratories require high-quality reference standards of Aldoxorubicin Hydrochloride, along with its associated impurities, metabolites, and stable isotope-labelled compounds, to perform rigorous quality control and method validation. These reference materials are critical for impurity profiling and ensuring the precise quantification of active pharmaceutical ingredients during pharmaceutical development and manufacturing. Utilizing certified analytical standards allows researchers to accurately detect degradation products and ensure compliance with regulatory specifications for this potent chemotherapy compound throughout the drug lifecycle.